August 22, 2022
Biotech And Drug Development (Audio) – Bloomberg
Dr. Amrie Grammer, co-founder of AMPEL BioSolutions, joins the show to discuss biotech and her company Hosted by Paul Sweeney…
August 22, 2022
Emergent BioSolutions to acquire PaxVax and two travel vaccines in $270M deal | Fierce Pharma
After getting smallpox vaccine ACAM2000 from Sanofi and an anthrax treatment called raxibacumab from GlaxoSmithKline, Emergent BioSolutions is buying again,…
August 22, 2022
Don’t get distracted over ARPA-H fight; let’s win the bigger prize | Maryland Daily Record
Congress has approved a new agency — the Advanced Research Projects Agency for Health (ARPA-H) — that will ‘supercharge’ breakthrough…
August 22, 2022
Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M | Fierce Pharma
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine…
August 19, 2022
8 new high priority funding opportunities
We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs…
August 19, 2022
Maryland’s RoosterBio and Seattle’s AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today…
August 19, 2022
Bio Tax Credit | Maryland Department of Commerce
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce…
